Long-term intrathecal administration of glycine prevents mechanical hyperalgesia in a rat model of neuropathic pain.
Neuropathic pain has been postulated to be mediated, in part, by amino acid neurotransmitters including glycine. The current study examined the effects of continuous intrathecal glycine administration (0.1 mumol 0.5 microliter-1 h-1) on the development of mechanical hyperalgesia and other features of neuropathic pain evoked by unilateral loose ligation of the sciatic nerve in the rat. Each hind paw was tested for withdrawal threshold to mechanical stimuli prior to, and after ligation at intervals of 3, 6, 9, 12 and 16 days. Pain behavior (posture and gait) and hind paw dystrophic features (redness and swelling) were also examined. Glycine increased the normal mechano-nociceptive responses and prevented the development of mechano-nociceptive hyperalgesia. Spontaneous nociceptive behavior and hind paw dystrophic features, seen in the saline treated rats, were significantly diminished. Our results suggest that spinal cord inhibitory glycinergic activity is important for normal mechano-receptive responsitivity and development of mechano-nociceptive hyperalgesia in this model.
Huang
W
W
Department of Neurosurgery, Baylor College of Medicine, Houston, TX 77030, USA.
Simpson
R K
RK
D000818:Animals; D005998:Glycine / Q000008:administration & dosage* / Q000494:pharmacology; D006930:Hyperalgesia / Q000517:prevention & control*; D007278:Injections, Spinal; D008026:Ligation; D008297:Male; D008465:Mechanoreceptors / Q000187:drug effects / Q000503:physiopathology; D009422:Nervous System Diseases / Q000209:etiology / Q000473:pathology / Q000503:physiopathology*; D009619:Nociceptors / Q000187:drug effects / Q000503:physiopathology; D010146:Pain / Q000209:etiology / Q000503:physiopathology; D010812:Physical Stimulation; D051381:Rats; D017207:Rats, Sprague-Dawley; D012584:Sciatic Nerve; D013997:Time Factors
D005998:Glycine